1,003 filings
PX14A6G
National Legal & Policy Center
27 Mar 24
Letter to shareholders
9:48am
ARS
2023 FY
JNJ
Johnson & Johnson
13 Mar 24
Annual report to shareholders
7:42am
DEFA14A
JNJ
Johnson & Johnson
13 Mar 24
Additional proxy soliciting materials
7:39am
DEFA14A
JNJ
Johnson & Johnson
13 Mar 24
Additional proxy soliciting materials
7:37am
DEF 14A
JNJ
Johnson & Johnson
Definitive proxy
13 Mar 24
7:35am
DFAN14A
brua4 smue4kcnzwrn5s
15 Feb 24
Additional proxy materials by non-management
5:23pm
DFAN14A
uiejbqf 9r943
29 Jan 24
Additional proxy materials by non-management
4:50pm
8-K
uqlnlx75
23 Jan 24
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
7:45am
DFAN14A
enwlrda9kpb76zlsor
9 Jan 24
Additional proxy materials by non-management
5:08pm
DFAN14A
9rdouc5 jsd9p
8 Jan 24
Additional proxy materials by non-management
5:22pm
DEFA14A
o7rpt blq
8 Jan 24
Additional proxy soliciting materials
8:22am
8-K
t5o nr4yly
5 Dec 23
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
4:42pm
8-K
7j66ol
5 Dec 23
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
7:52am
8-K
rrxy2emj gp4cr0x4wf
30 Nov 23
Strengthens position in high-growth MedTech segments
4:30pm
8-K
3zotyn0wy ng
27 Nov 23
Departure of Directors or Certain Officers
4:56pm
8-K
z4gth
23 Oct 23
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
4:48pm
8-K
bxbcm ia651
17 Oct 23
Results of Operations and Financial Condition
7:33am
8-K
l9h4vwfvbw52lz5 q6
30 Aug 23
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
7:46am